等待开盘 10-09 09:30:00 美东时间
+5.940
+2.79%
今日重点评级关注:Maxim Group:维持Gain Therapeutics"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Icecure Medical"买入"评级,目标价从2美元升至2.5美元
10-08 09:14
Bowman Consulting Group (NASDAQ:BWMN) said on Monday that it has acquired the assets of California-based Sierra Overhead Analytics and its technology affiliate ORCaS, two companies under common contro...
10-06 20:17
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从15美元升至18美元;Ascendiant Capital:维持Surgepays"买入"评级,目标价从9美元升至9.5美元
10-06 08:35
In the last three months, 15 analysts have published ratings on MasTec (NYSE:MT...
10-04 02:01
In the current session, the stock is trading at $216.84, after a 0.67% increase...
10-04 02:01
Citigroup analyst Andrew Kaplowitz maintains MasTec (NYSE:MTZ) with a Buy and raises the price target from $219 to $248.
10-03 22:55
今日重点评级关注:JMP证券:维持Ocular Therapeutix"跑赢大市"评级,目标价从20美元升至29美元;汇丰银行:上调Banco BBVA Argentina评级至"买入",目标价从21美元下调至17美元
10-02 15:08
今日重点评级关注:Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从12美元升至12.5美元;Oppenheimer:维持Immuneering"跑赢大市"评级,目标价从21美元升至30美元
09-26 09:45
Roth Capital analyst Philip Shen maintains MasTec (NYSE: MTZ) with a Buy and raises the price target from $210 to $250.
09-26 02:05
MasTec (NYSE:MTZ) has outperformed the market over the past 5 years by 21.98% o...
09-20 05:31